Also trades as: TVGNW (NASDAQ) · $vol 0M
TVGN NASDAQ
Tevogen Bio Holdings Inc.
1W: -10.9%
1M: -9.9%
3M: +10.2%
YTD: +1675.7%
1Y: +710.5%
3Y: -40.4%
$6.98
+0.26 (+3.87%)
Weekly Expected Move ±7.2%
$6
$6
$6
$7
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$29.1M
52W Range3.636-39.5
Volume1,677
Avg Volume21,124
Beta0.19
Dividend—
Analyst Ratings
Company Info
CEORyan H. Saadi
Employees18
SectorHealthcare
IndustryBiotechnology
IPO Date2022-01-05
Websitetevogen.com
15 Independence Blvd
Warren, NJ 07059
US
Warren, NJ 07059
US
877 838 6436
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.
Latest News
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
12 Health Care Stocks Moving In Wednesday's Intraday Session
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
Tevogen Bio Holdings reports Q1 results; operating loss falls 48%
12 Health Care Stocks Moving In Tuesday's After-Market Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Saadi Ryan H. | A-Award | 8,000,000 | — | 2026-09-14 |
| Desai Kirti | A-Award | 750,000 | — | 2026-09-14 |
| Goh Keow Lin | A-Award | 75,000 | — | 2026-09-11 |
| PODLOGAR SUSAN M | A-Award | 75,000 | — | 2026-09-11 |
| Sordillo Victor J. | A-Award | 75,000 | — | 2026-09-11 |